123 related articles for article (PubMed ID: 23872275)
1. Therapeutic enhancement of vascular-targeted photodynamic therapy by inhibiting proteasomal function.
Li Z; Agharkar P; Chen B
Cancer Lett; 2013 Oct; 339(1):128-34. PubMed ID: 23872275
[TBL] [Abstract][Full Text] [Related]
2. Comparison between endothelial and tumor cells in the response to verteporfin-photodynamic therapy and a PI3K pathway inhibitor.
Fateye B; Wan A; Yang X; Myers K; Chen B
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):19-26. PubMed ID: 25636781
[TBL] [Abstract][Full Text] [Related]
3. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy.
Chen B; Pogue BW; Hoopes PJ; Hasan T
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1216-26. PubMed ID: 15752904
[TBL] [Abstract][Full Text] [Related]
4. Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy.
Chen B; Crane C; He C; Gondek D; Agharkar P; Savellano MD; Hoopes PJ; Pogue BW
Int J Cancer; 2008 Aug; 123(3):695-701. PubMed ID: 18498134
[TBL] [Abstract][Full Text] [Related]
5. Combination of phosphatidylinositol 3-kinases pathway inhibitor and photodynamic therapy in endothelial and tumor cells.
Fateye B; Li W; Wang C; Chen B
Photochem Photobiol; 2012; 88(5):1265-72. PubMed ID: 22506666
[TBL] [Abstract][Full Text] [Related]
6. Intravital microscopic analysis of vascular perfusion and macromolecule extravasation after photodynamic vascular targeting therapy.
He C; Agharkar P; Chen B
Pharm Res; 2008 Aug; 25(8):1873-80. PubMed ID: 18446275
[TBL] [Abstract][Full Text] [Related]
7. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):720-7. PubMed ID: 15701861
[TBL] [Abstract][Full Text] [Related]
8. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
[TBL] [Abstract][Full Text] [Related]
9. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
[TBL] [Abstract][Full Text] [Related]
10. Targeting Phosphatidylinositol 3-Kinase Signaling Pathway for Therapeutic Enhancement of Vascular-Targeted Photodynamic Therapy.
Kraus D; Palasuberniam P; Chen B
Mol Cancer Ther; 2017 Nov; 16(11):2422-2431. PubMed ID: 28835385
[TBL] [Abstract][Full Text] [Related]
11. Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications.
Chen B; Pogue BW; Luna JM; Hardman RL; Hoopes PJ; Hasan T
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):917-23. PubMed ID: 16467106
[TBL] [Abstract][Full Text] [Related]
12. Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.
Hu Z; Rao B; Chen S; Duanmu J
BMC Cancer; 2010 May; 10():235. PubMed ID: 20504328
[TBL] [Abstract][Full Text] [Related]
13. Modulation of EGFR and ROS induced cytochrome c release by combination of photodynamic therapy and carboplatin in human cultured head and neck cancer cells and tumor xenograft in nude mice.
Hwang H; Biswas R; Chung PS; Ahn JC
J Photochem Photobiol B; 2013 Nov; 128():70-7. PubMed ID: 24035846
[TBL] [Abstract][Full Text] [Related]
14. The role of strong hypoxia in tumors after treatment in the outcome of bacteriochlorin-based photodynamic therapy.
Krzykawska-Serda M; Dąbrowski JM; Arnaut LG; Szczygieł M; Urbańska K; Stochel G; Elas M
Free Radic Biol Med; 2014 Aug; 73():239-51. PubMed ID: 24835769
[TBL] [Abstract][Full Text] [Related]
15. A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapy.
Shi W; Yin Y; Wang Y; Zhang B; Tan P; Jiang T; Mei H; Deng J; Wang H; Guo T; Pang Z; Hu Y
Oncotarget; 2017 May; 8(19):32212-32227. PubMed ID: 27793028
[TBL] [Abstract][Full Text] [Related]
16. Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy.
Cheng Y; Cheng H; Jiang C; Qiu X; Wang K; Huan W; Yuan A; Wu J; Hu Y
Nat Commun; 2015 Nov; 6():8785. PubMed ID: 26525216
[TBL] [Abstract][Full Text] [Related]
17. Anti-metastatic and pro-apoptotic effects elicited by combination photodynamic therapy with sonodynamic therapy on breast cancer both in vitro and in vivo.
Wang P; Li C; Wang X; Xiong W; Feng X; Liu Q; Leung AW; Xu C
Ultrason Sonochem; 2015 Mar; 23():116-27. PubMed ID: 25465095
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial Malfunctioning, Proteasome Arrest and Apoptosis in Cancer Cells by Focused Intracellular Generation of Oxygen Radicals.
Postiglione I; Chiaviello A; Barra F; Roscetto E; Soriano AA; Catania MR; Palumbo G; Pierantoni GM
Int J Mol Sci; 2015 Aug; 16(9):20375-91. PubMed ID: 26343643
[TBL] [Abstract][Full Text] [Related]
19. Monocytic delivery of therapeutic oxygen bubbles for dual-modality treatment of tumor hypoxia.
Huang WC; Shen MY; Chen HH; Lin SC; Chiang WH; Wu PH; Chang CW; Chiang CS; Chiu HC
J Control Release; 2015 Dec; 220(Pt B):738-50. PubMed ID: 26374945
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of oxygen consumption of culture medium and in vitro photodynamic effect of talaporfin sodium in lung tumor cells.
Tomioka Y; Kushibiki T; Awazu K
Photomed Laser Surg; 2010 Jun; 28(3):385-90. PubMed ID: 19860571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
